#Coherus also says no plans to launch its #biosimilaradalimumab #CHS1420 till mid-2022; been a good week for #AbbVie #Humira so far
#Coherus also says no plans to launch its #biosimilaradalimumab #CHS1420 till mid-2022; been a good week for #AbbVie #Humira so far